ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
213 |
89K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
213
|
89K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
213 |
89K |
19 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
213
|
89K
|
19
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
624 |
199K |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
624
|
199K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ma420
|
83 |
24K |
13 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
83
|
24K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
4 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
531
|
178K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
2 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
531
|
178K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
2 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
531
|
178K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
1 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
73
|
23K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
14 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
73
|
23K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
16 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
73
|
23K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
11 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
73
|
23K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
19 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
73
|
23K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
ma420
|
37 |
11K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
37
|
11K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
ma420
|
37 |
11K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
37
|
11K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
624 |
199K |
10 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
624
|
199K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
624 |
199K |
8 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
624
|
199K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
531
|
178K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
19 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
531
|
178K
|
19
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity to Present at 3 World Leading Conferences
|
|
ma420
|
4 |
1.7K |
19 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
4
|
1.7K
|
19
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
213 |
89K |
8 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
213
|
89K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
213 |
89K |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
213
|
89K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
624 |
199K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
624
|
199K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
531
|
178K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
531
|
178K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
531
|
178K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
531
|
178K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
11 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
531
|
178K
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.3M |
11 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
21K
|
7.3M
|
11
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
174 |
81K |
10 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
174
|
81K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ma420
|
230 |
103K |
29 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
230
|
103K
|
29
|
|
ASX - By Stock
|
DXB |
DXB - Research & Valuation
|
|
ma420
|
230 |
103K |
23 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
230
|
103K
|
23
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
213 |
89K |
16 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
213
|
89K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
12 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
531
|
178K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
531
|
178K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
606 |
182K |
11 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
606
|
182K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ma420
|
1 |
976 |
37 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1
|
976
|
37
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
624 |
199K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
624
|
199K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
606 |
182K |
20 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
606
|
182K
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
ma420
|
73 |
23K |
36 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
73
|
23K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
1.7K |
615K |
14 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.7K
|
615K
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.3M |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.3M |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
21K
|
7.3M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.3M |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
21K
|
7.3M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
606 |
182K |
12 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
606
|
182K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
606 |
182K |
2 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
606
|
182K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
531 |
178K |
5 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
531
|
178K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
606 |
182K |
16 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
606
|
182K
|
16
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Receives $10 Million in Placement Funds
|
|
ma420
|
5 |
2.0K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
33K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
127
|
33K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
33K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
127
|
33K
|
0
|
|